Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328717 · ClinicalTrials.gov registry record · NA
Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01328717 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 78 participants.
The verdict
NCT01328717, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Subjects with diabetes and study staff used an investigational blood glucose monitoring system.
Interventions
- DEVICE Contour Link Investigational Blood Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-12 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01328717
The ClinicalTrials.gov registry entry for NCT01328717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contour Link Investigational Blood Glucose Monitoring System is the first listed.
NCT01328717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01328717 about?
NCT01328717 is a clinical study titled "Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial". Subjects with diabetes and study staff used an investigational blood glucose monitoring system.
What is the current status of trial NCT01328717?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2010-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01328717?
The interventions under investigation include: Contour Link Investigational Blood Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01328717?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.